At Novo Nordisk Capital Markets Day, Co. CEO Says I Would Not Rule Out Acquiring Products Or Assets Which Are Already On The Market; Financial Impact From Compounders Has Gotten Less And Less
https://edge.media-server.com/mmc/p/xdjeyf7u/
Share
Why It Matters
Novo Nordisk's leader said the company might buy existing medicines or products. He also noted that copycat drugs are hurting the company less now.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.